Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 23:17:1105562.
doi: 10.3389/fnins.2023.1105562. eCollection 2023.

Patient perspectives on the need for improved hearing rehabilitation: A qualitative survey study of German cochlear implant users

Affiliations

Patient perspectives on the need for improved hearing rehabilitation: A qualitative survey study of German cochlear implant users

Victoria Hunniford et al. Front Neurosci. .

Abstract

Background: The electrical cochlear implant (eCI) partially restores hearing in individuals affected by profound hearing impairment (HI) or deafness. However, the limited resolution of sound frequency coding with eCIs limits hearing in daily situations such as group conversations. Current research promises future improvements in hearing restoration which may involve gene therapy and optical stimulation of the auditory nerve, using optogenetics. Prior to the potential clinical translation of these technologies, it is critical that patients are engaged in order to align future research agendas and technological advancements with their needs.

Methods: Here, we performed a survey study with hearing impaired, using an eCI as a means of hearing rehabilitation. We distributed a questionnaire to 180 adult patients from the University Medical Center Göttingen's Department of Otolaryngology who were actively using an eCI for 6 months or more during the time of the survey period. Questions revolved around patients needs, and willingness to accept hypothetical risks or drawbacks associated with an optical CI (oCI).

Results: Eighty-one participants responded to the questionnaire; 68% were greater than 60 years of age and 26% had bilateral eCIs. Participants expressed a need for improving the performance beyond that experienced with their current eCI. Primarily, they desired improved speech comprehension in background noise, greater ability to appreciate music, and more natural sound impression. They expressed a willingness for engaging with new technologies for improved hearing restoration. Notably, participants were least concerned about hypothetically receiving a gene therapy necessary for the oCI implant; but expressed greater reluctance to hypothetically receiving an implant that had yet to be evaluated in a human clinical trial.

Conclusion: This work provides a preliminary step in engaging patients in the development of a new technology that has the potential to address the limitations of electrical hearing rehabilitation.

Keywords: cochlear implant; gene therapy; hearing rehabilitation; optogenetics; survey study; translational research.

PubMed Disclaimer

Conflict of interest statement

DK and TM are co-founders of the OptoGenTech company that works toward clinical translation of the optical cochlear implant. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Participants’ rating of importance for five hypothetical improvements in a new cochlear implant (CI). Percent out of N = 80 completed responses (1 non-respondent). Gray quadrant indicates the percent of participants that rated the improvement from 0 to 2; light green indicates the percent that rated 3–5; light blue indicates that percent that rated 6–8; and dark blue indicated the percent that rated 9–10.
FIGURE 2
FIGURE 2
Participants’ acceptance of hypothetical risks and drawback associated with a new cochlear implant (CI). Percent values are out of the total number of participants who completed each question (N = 76–81). Participants were asked “If you were to be hypothetically implanted with a new CI that was expected to improve the limitations mentioned in Section I of the questionnaire (Supplementary material 2), which of the following risks and disadvantages would you accept in this new CI?” Dark blue indicates an response of “yes,” and light blue indicated a response of “no.”

Similar articles

Cited by

References

    1. Adel Y., Nagel S., Weissgerber T., Baumann U., Macherey O. (2019). Pitch matching in cochlear implant users with single-sided deafness: effects of electrode position and acoustic stimulus type. Front. Neurosci. 13:1119. 10.3389/fnins.2019.01119 - DOI - PMC - PubMed
    1. Aiyegbusi O. L., Macpherson K., Elston L., Myles S., Washington J., Sungum N., et al. (2020). Patient and public perspectives on cell and gene therapies: a systematic review. Nat. Commun. 11:6265. 10.1038/s41467-020-20096-1 - DOI - PMC - PubMed
    1. Bali B., Lopez de la Morena D., Mittring A., Mager T., Rankovic V., Huet A. T., et al. (2021). Utility of red-light ultrafast optogenetic stimulation of the auditory pathway. EMBO Mol. Med. 2021:e13391. 10.15252/emmm.202013391 - DOI - PMC - PubMed
    1. Bali B., Gruber-Dujardin E., Kusch K., Rankovic V., Moser T. (2022). Analyzing efficacy, stability, and safety of AAV-mediated optogenetic hearing restoration in mice. Life Sci Alliance. 5:e202101338. 10.26508/lsa.202101338 - DOI - PMC - PubMed
    1. Begley C. G., Ellis L. M. (2012). Raise standards for preclinical cancer research. Nature 483 531–533. 10.1038/483531a - DOI - PubMed

LinkOut - more resources